Bioxytran, Inc. (BIXT)
Develops drug treatments for oxygen deprivation in tissues and viral infections.
$0.02-0.06%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-75.1%
The outlook
BIXT is trading near its 52-week low and well below both its 50- and 200-day moving averages, signaling a sustained downtrend. The stock sits at the bottom of its annual range with minimal analyst coverage and a bearish sentiment score. Current price action shows no upward momentum over recent timeframes.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.6M
52-wk high
$0.10
52-wk low
$0.02
50-day avg
$0.03
200-day avg
$0.05
Trailing P/E
—